Treatt (TET) Competitors GBX 255 -4.00 (-1.54%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock TET vs. SCPA, ESNT, SYNT, ZTF, IOF, WCH, ITX, DCTA, BIOM, and HAYDShould you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Scapa Group (SCPA), Essentra (ESNT), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Biome Technologies (BIOM), and Haydale Graphene Industries (HAYD). These companies are all part of the "specialty chemicals" industry. Treatt vs. Scapa Group Essentra Synthomer Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Biome Technologies Haydale Graphene Industries Treatt (LON:TET) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations. Is TET or SCPA more profitable? Treatt has a net margin of 7.88% compared to Scapa Group's net margin of 0.00%. Treatt's return on equity of 8.09% beat Scapa Group's return on equity.Company Net Margins Return on Equity Return on Assets Treatt7.88% 8.09% 6.72% Scapa Group N/A N/A N/A Do institutionals and insiders believe in TET or SCPA? 50.9% of Treatt shares are held by institutional investors. 13.4% of Treatt shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer TET or SCPA? In the previous week, Treatt's average media sentiment score of 0.00 equaled Scapa Group'saverage media sentiment score. Company Overall Sentiment Treatt Neutral Scapa Group Neutral Does the MarketBeat Community favor TET or SCPA? Scapa Group received 33 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 56.27% of users gave Scapa Group an outperform vote. CompanyUnderperformOutperformTreattOutperform Votes16068.97% Underperform Votes7231.03% Scapa GroupOutperform Votes19356.27% Underperform Votes15043.73% Do analysts recommend TET or SCPA? Treatt currently has a consensus target price of GBX 650, suggesting a potential upside of 154.90%. Given Treatt's stronger consensus rating and higher probable upside, research analysts plainly believe Treatt is more favorable than Scapa Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treatt 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, TET or SCPA? Treatt has higher earnings, but lower revenue than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreatt£142.31M1.08£11.22M£18.5113.78Scapa Group£281.80M0.00N/A-£29.30N/A SummaryTreatt beats Scapa Group on 11 of the 13 factors compared between the two stocks. Get Treatt News Delivered to You Automatically Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TET vs. The Competition Export to ExcelMetricTreattSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£154.18M£8.18B£3.03B£2.56BDividend Yield2.00%3.58%5.18%4.84%P/E Ratio13.7812.6174.71132.42Price / Sales1.0849.4425,549,533,275,675,700.00240,284.86Price / Cash165.4319.2524.3228.16Price / Book1.105.195.214.55Net Income£11.22M£220.83M£155.11M£5.85B7 Day Performance4.08%3.17%1.18%2.72%1 Month Performance-23.88%15.61%3.06%8.66%1 Year Performance-47.58%-17.48%19.04%110.93% Treatt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TETTreatt2.3179 of 5 starsGBX 255-1.5%GBX 650+154.9%-46.7%£154.18M£142.31M13.78350Dividend IncreaseNews CoverageHigh Trading VolumeSCPAScapa GroupN/AN/AN/AN/A£402.98M£281.80M-7.321,461ESNTEssentra2.954 of 5 starsGBX 89.70-2.8%GBX 206.67+130.4%-48.9%£257.83M£309.74M73.89350SYNTSynthomer2.2989 of 5 starsGBX 80.10-1.2%GBX 225+180.9%-66.0%£131.35M£1.87B-1.614,200ZTFZotefoamsN/AGBX 257+1.2%N/A-33.8%£123.61M£131.66M12.44549Positive NewsGap DownIOFIofina2.0585 of 5 starsGBX 20.90+2.0%GBX 36.25+73.4%+12.3%£50.18M£61.34M14.6795Gap DownHigh Trading VolumeWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 98-4.4%N/A-41.9%£13.22M£5.28M-8.8717DCTADirecta PlusN/AGBX 7.50+3.4%N/A-61.2%£10.09M£20.29M-1.33187BIOMBiome TechnologiesN/AGBX 9.75-5.3%N/A-87.7%£5.03M£78.36M-0.2827Gap DownHAYDHaydale Graphene IndustriesN/AGBX 0.13flatN/A-69.7%£4.89M£14.20M-0.2767 Related Companies and Tools Related Companies SCPA Competitors ESNT Competitors SYNT Competitors ZTF Competitors IOF Competitors WCH Competitors ITX Competitors DCTA Competitors BIOM Competitors HAYD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TET) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treatt plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Treatt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TET Stock Free TET Stock Alerts